You just read:

Novel Anti-IL-6 Antibody for Rheumatoid Arthritis from WuXi-MedImmune Joint Venture Receives Clinical Trial Permit (CTP) from CFDA

News provided by

WuXi AppTec

Jan 18, 2017, 05:00 ET